SEC filing · 8-K

Aethlon Medical Inc: Change in control

Aethlon Medical agreed to merge with North Immunology in an all-stock transaction supported by an approximately $180 million private placement.

Filed September 17, 2026

Positive for the company

What happened

Aethlon Medical entered into a definitive merger agreement under which North Immunology will merge with Aethlon subsidiaries.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Aethlon Medical Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.